Home » Topics » BioWorld Science

BioWorld Science
RSS

Onco TCS slated to enter phase II

May 3, 1996

AG-2034 data reported at AACR

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...